Alzheimer's disease is a condition that leads to significant brain changes, affecting over six million people in the United States alone. Individuals with Alzheimer's often experience a progressive decline in cognitive function and memory, which can manifest as memory loss, personality changes, and impaired judgment. As the most common type of dementia, Alzheimer's disease is a critical focus area for research.<br />
<br />
Shannel Kassis Elhelou, Psy.D., a geropsychology and neuropsychology fellow at Pacific Neuroscience Institute's Brain Wellness and Lifestyle Programs in Santa Monica, CA, emphasized the profound impact of Alzheimer's on quality of life and daily functioning:<br />
<br />
"Alzheimer's disease significantly impacts quality of life and function through progressive declines in memory, cognitive functioning (attention, processing speed, problem-solving, word finding), tasks of daily living (managing finances, driving, medication management, household duties), as well as changes in mood (increased irritability, anxiety, depression, or apathy)," Elhelou told Medical News Today.<br />
<br />
Elhelou added that Alzheimer's also affects physical health over time, reducing mobility and increasing the risk of falls, which can lead to social isolation and substantial caregiver burden, further diminishing the quality of life for both individuals and their caregivers.<br />
<br />
While there are medications available to help manage Alzheimer's disease, experts are increasingly interested in how lifestyle interventions might also benefit those affected. A recent study focused on evaluating the effectiveness of non-medication interventions for individuals in the early stages of Alzheimer's disease.<br />
<br />
Exploring Lifestyle Changes to Prevent Alzheimer's<br />
In a randomized, controlled clinical trial, researchers investigated whether a combination of lifestyle interventions could benefit people with mild cognitive impairment or early dementia due to Alzheimer's disease. The study included 51 participants with an average age of 73.5 years, excluding those with moderate or severe dementia or those unable to participate in regular exercise.<br />
<br />
Participants were divided into two groups: a control group receiving standard care and an intervention group receiving standard care plus four key lifestyle interventions:<br />
<br />
A whole-foods, minimally processed plant-based diet with specific supplements and low levels of harmful fats and refined carbohydrates.<br />
Moderate exercise for at least thirty minutes daily and mild strength training three times a week.<br />
Stress management techniques such as meditation, yoga, and breathing exercises.<br />
Regular participation in support groups three times a week.<br />
The intervention period lasted 20 weeks, with researchers providing support for diet, exercise, stress management, and access to support groups. The success of these interventions was assessed using several tools, including the Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Clinical Dementia Rating.<br />
<br />
Findings and Implications<br />
The control group showed declines in all cognitive and functional assessments, while the intervention group showed improvement in three out of four assessments and less progression in the fourth. Additionally, the intervention group exhibited improvements in microbiome configuration and relevant biomarkers compared to the control group.<br />
<br />
Dean Ornish, founder and president of the nonprofit Preventive Medicine Research Institute and clinical professor of medicine at the University of California, San Francisco, highlighted the significance of the findings:<br />
<br />
"Our research is unique as it's the first randomized controlled clinical trial demonstrating that an intensive lifestyle intervention, without drugs, significantly improved cognition and function in many patients with mild cognitive impairment or early dementia due to Alzheimer's disease after 20 weeks," Ornish told Medical News Today.<br />
<br />
Ornish noted a significant correlation between the degree of lifestyle changes and the improvements in cognition and function, suggesting that more substantial lifestyle changes led to greater benefits.<br />
<br />
While not all participants in the intervention group experienced improvements, 71% either improved or remained unchanged in the CGIC test, whereas none in the control group improved, with 68% worsening.<br />
<br />
Study Limitations and Future Directions<br />
Despite promising results, the study has several limitations, including a small sample size and lack of generalizability. The study excluded individuals without a caregiver to assist with adherence and did not include brain structure measurements. The intervention period was relatively short at 20 weeks, and future research could benefit from longer intervention and follow-up periods, as well as a more diverse participant group.<br />
<br />
The complexity of the interventions also makes it unclear which specific components were most beneficial. Additionally, reliance on participant self-reporting introduces potential inaccuracies.<br />
<br />
Researchers acknowledge the need for cautious interpretation of the degree of lifestyle change required to stop or improve cognitive decline, as the combined data from both groups meant the trial was no longer randomized for this analysis.<br />
<br />
Hope for the Future<br />
The study's findings offer hope for those affected by Alzheimer's disease and suggest the potential for more extensive research on lifestyle interventions. Shannel Kassis Elhelou expressed optimism about the implications:<br />
<br />
"I hope to see more providers discussing this information with their patients, and I am enthusiastic about future research in this area. These findings underscore the potential of non-pharmacological interventions in the treatment of mild cognitive impairment and early-stage Alzheimer's disease. Ongoing research can further support their ability to influence healthcare guidelines by promoting lifestyle modifications as a crucial strategy for slowing the progression of MCI and early-stage Alzheimer's disease," Elhelou said.<br />
<br />
Future studies will be vital in confirming these findings and establishing lifestyle interventions as a standard approach to managing and potentially preventing Alzheimer's disease.Alzheimer's disease is a condition that leads to significant brain changes, affecting over six million people in the United States alone. Individuals with Alzheimer's often experience a progressive decline in cognitive function and memory, which can manifest as memory loss, personality changes, and impaired judgment. As the most common type of dementia, Alzheimer's disease is a critical focus area for research.<br />
<br />
Shannel Kassis Elhelou, Psy.D., a geropsychology and neuropsychology fellow at Pacific Neuroscience Institute's Brain Wellness and Lifestyle Programs in Santa Monica, CA, emphasized the profound impact of Alzheimer's on quality of life and daily functioning:<br />
<br />
"Alzheimer's disease significantly impacts quality of life and function through progressive declines in memory, cognitive functioning (attention, processing speed, problem-solving, word finding), tasks of daily living (managing finances, driving, medication management, household duties), as well as changes in mood (increased irritability, anxiety, depression, or apathy)," Elhelou told Medical News Today.<br />
<br />
Elhelou added that Alzheimer's also affects physical health over time, reducing mobility and increasing the risk of falls, which can lead to social isolation and substantial caregiver burden, further diminishing the quality of life for both individuals and their caregivers.<br />
<br />
While there are medications available to help manage Alzheimer's disease, experts are increasingly interested in how lifestyle interventions might also benefit those affected. A recent study focused on evaluating the effectiveness of non-medication interventions for individuals in the early stages of Alzheimer's disease.<br />
<br />
Exploring Lifestyle Changes to Prevent Alzheimer's<br />
In a randomized, controlled clinical trial, researchers investigated whether a combination of lifestyle interventions could benefit people with mild cognitive impairment or early dementia due to Alzheimer's disease. The study included 51 participants with an average age of 73.5 years, excluding those with moderate or severe dementia or those unable to participate in regular exercise.<br />
<br />
Participants were divided into two groups: a control group receiving standard care and an intervention group receiving standard care plus four key lifestyle interventions:<br />
<br />
A whole-foods, minimally processed plant-based diet with specific supplements and low levels of harmful fats and refined carbohydrates.<br />
Moderate exercise for at least thirty minutes daily and mild strength training three times a week.<br />
Stress management techniques such as meditation, yoga, and breathing exercises.<br />
Regular participation in support groups three times a week.<br />
The intervention period lasted 20 weeks, with researchers providing support for diet, exercise, stress management, and access to support groups. The success of these interventions was assessed using several tools, including the Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Clinical Dementia Rating.<br />
<br />
Findings and Implications<br />
The control group showed declines in all cognitive and functional assessments, while the intervention group showed improvement in three out of four assessments and less progression in the fourth. Additionally, the intervention group exhibited improvements in microbiome configuration and relevant biomarkers compared to the control group.<br />
<br />
Dean Ornish, founder and president of the nonprofit Preventive Medicine Research Institute and clinical professor of medicine at the University of California, San Francisco, highlighted the significance of the findings:<br />
<br />
"Our research is unique as it's the first randomized controlled clinical trial demonstrating that an intensive lifestyle intervention, without drugs, significantly improved cognition and function in many patients with mild cognitive impairment or early dementia due to Alzheimer's disease after 20 weeks," Ornish told Medical News Today.<br />
<br />
Ornish noted a significant correlation between the degree of lifestyle changes and the improvements in cognition and function, suggesting that more substantial lifestyle changes led to greater benefits.<br />
<br />
While not all participants in the intervention group experienced improvements, 71% either improved or remained unchanged in the CGIC test, whereas none in the control group improved, with 68% worsening.<br />
<br />
Study Limitations and Future Directions<br />
Despite promising results, the study has several limitations, including a small sample size and lack of generalizability. The study excluded individuals without a caregiver to assist with adherence and did not include brain structure measurements. The intervention period was relatively short at 20 weeks, and future research could benefit from longer intervention and follow-up periods, as well as a more diverse participant group.<br />
<br />
The complexity of the interventions also makes it unclear which specific components were most beneficial. Additionally, reliance on participant self-reporting introduces potential inaccuracies.<br />
<br />
Researchers acknowledge the need for cautious interpretation of the degree of lifestyle change required to stop or improve cognitive decline, as the combined data from both groups meant the trial was no longer randomized for this analysis.<br />
<br />
Hope for the Future<br />
The study's findings offer hope for those affected by Alzheimer's disease and suggest the potential for more extensive research on lifestyle interventions. Shannel Kassis Elhelou expressed optimism about the implications:<br />
<br />
"I hope to see more providers discussing this information with their patients, and I am enthusiastic about future research in this area. These findings underscore the potential of non-pharmacological interventions in the treatment of mild cognitive impairment and early-stage Alzheimer's disease. Ongoing research can further support their ability to influence healthcare guidelines by promoting lifestyle modifications as a crucial strategy for slowing the progression of MCI and early-stage Alzheimer's disease," Elhelou said.<br />
<br />
Future studies will be vital in confirming these findings and establishing lifestyle interventions as a standard approach to managing and potentially preventing Alzheimer's disease.